Sun Pharmaceutical Industries Limited
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 US FDA determines Baska facility inspection classification as OAI |SUBJECT: General Updates
Source link
